Source: cases/15usc1/f-supp-864-1175-levine-v-central-florida-medical.case
Case source: https://www.neochart.com/catalog/cases/f-supp/volume_864/1175_01/index.html
To be a proper party, a plaintiff must have suffered an antitrust injury and must be an efficient enforcer of the antitrust laws.
Whatever may be said about his personal injuries, his suspension from ORMC and Sand Lake does not constitute an antitrust injury.
Therefore, a doctor may establish the first two elements of a Section 1 claim by attacking the peer review process and by presenting evidence that suggests the review was a sham and pretextual.
For the purpose of deciding Defendants’ motion, the Court will assume that Plaintiff can establish the first two elements of a Section 1 claim.
If the antitrust violation involves “ ‘a naked restriction on price or output’ ” or, similarly, if a plaintiff can provide “‘proof of actual detrimental effects,’ ” failure to prove market power will not defeat a plaintiff’s claim.
Upon review of relevant caselaw, the Court concludes that the proper analysis in this case is the rule of reason.
Unlike the plaintiff in Boczar, Plaintiff must establish market power in order to maintain a claim under Section 1. This he has not done.
He hopes to benefit from the Defendant’s allegedly anticompetitive conduct.
He merely hopes to profit from the allegedly anticompetitive conduct of others.
A second factor is the nature of the plaintiffs damages claims. Id. If the claims are highly speculative,' the plaintiff may not have standing.
It appears that any damages Plaintiff may be able to claim are highly speculative. Therefore, Plaintiff is not an efficient enforcer of this alleged antitrust violation.
Plaintiff must, therefore, define the market and establish market power.
Since the competitive effect is not immediately obvious, the Court would be unwilling to apply a per se approach in this case.
casedsl 1
case /f-supp/864/1175-01
name Levine v. Central Florida Medical Affiliates, Inc.
cite 864 F. Supp. 1175 (1994)
court United States District Court for the Middle District of Florida
date 1994-08-31
url catalog/cases/f-supp/volume_864/1175_01/index.html
source ir/caselaw/f_supp_864.jsonl sha1=c5a6a9e3cb8695532a128ee2c19fd7b9acdfa401 chars=40511
law 15usc1
role applied
posture civil; private damages suit by excluded physician; defendants' motions for partial summary judgment on Count III (hospital privilege suspension) and Count I (closed-panel PPO) granted
result claimant-lost
element injury : not-satisfied [no-evidence]
count Count III (concerted suspension of hospital privileges)
party Sand Lake, ORHS/ORMC
variant antitrust-injury/suspended-physician-still-practicing-elsewhere
fact @3978..4198 [supports] | Plaintiff asserts that Sand Lake, ORMC and another internist conspired to blacklist Plaintiff by summarily suspending his staff and emergency room privileges and circulating to other doctors the notice of his suspension.
fact @6729..6859 [cuts-against] | During this period of time, Plaintiff had staff privileges at Florida Hospital’s several campuses, Charter Hospital and Glenbeigh.
fact @6936..7049 [cuts-against] | Immediately after his suspension, Plaintiff began using Florida Hospital for the hospitalization of his patients.
fact @10956..11089 [cuts-against] | During the time his privileges were suspended at Sand Lake and ORMC, Plaintiff was able to admit patients to several other hospitals.
rule @4861..4990 | To be a proper party, a plaintiff must have suffered an antitrust injury and must be an efficient enforcer of the antitrust laws.
held @13281..13410 | Whatever may be said about his personal injuries, his suspension from ORMC and Sand Lake does not constitute an antitrust injury.
gloss Five-month suspension at one hospital system harmed the competitor, not competition: no reduction in services, number of internists, or effect on price. Distinguished from cases where the exclusion effectively ended the doctor's ability to practice in the area.
element agreement : satisfied [assumed]
scope alternative
count Count III
variant hospital-and-medical-staff/sham-peer-review
rule @15008..15201 | Therefore, a doctor may establish the first two elements of a Section 1 claim by attacking the peer review process and by presenting evidence that suggests the review was a sham and pretextual.
held @15202..15345 | For the purpose of deciding Defendants’ motion, the Court will assume that Plaintiff can establish the first two elements of a Section 1 claim.
gloss Assumed arguendo inside the court's "even if Plaintiff has standing" alternative section (court could not locate plaintiff's record cites); hospital and its staff are legally capable of conspiring under circuit law. The assumption covers "the first two elements" (agreement and unlawful objective) together.
element restraint.rule-of-reason : not-satisfied [no-evidence]
scope alternative
count Count III
variant anticompetitive-effect/single-competitor-excluded-no-market-proof
fact @18005..18133 [supports] | Plaintiff has suggested that this ease involves a group boycott, which traditionally has been categorized as a per se violation.
fact @18816..18930 [cuts-against absent] | As Defendants note, Plaintiff has not attempted to define the relevant market or provide evidence of market power.
fact @20199..20266 [cuts-against] | After his suspension, he went on to compete effectively in Orlando.
rule @17680..17911 | If the antitrust violation involves “ ‘a naked restriction on price or output’ ” or, similarly, if a plaintiff can provide “‘proof of actual detrimental effects,’ ” failure to prove market power will not defeat a plaintiff’s claim.
held @18247..18360 | Upon review of relevant caselaw, the Court concludes that the proper analysis in this case is the rule of reason.
held @20267..20404 | Unlike the plaintiff in Boczar, Plaintiff must establish market power in order to maintain a claim under Section 1. This he has not done.
gloss Alternative merits holding ("Even if the Court were to assume that Plaintiff has standing"): privilege suspension is not a per se group boycott; with no actual detrimental effects shown, market definition and market power were required and wholly absent. The mode-of-analysis choice (first held line) and the failure of proof under it (second held line) are one block because the claim fails under the selected mode.
element injury : not-satisfied [no-evidence]
count Count I (exclusion from closed-panel PPO)
party CFMA, Healthchoice
theory plaintiff wants admission to the closed panel (deposition version)
variant antitrust-injury/plaintiff-seeks-share-of-supracompetitive-profits
fact @3400..3520 [supports] | He was informed that there were already enough internists in his quadrant of the city to meet HealthcAoice member needs.
fact @26205..26391 [supports] | Plaintiff responded, “I haven’t sat down -with a pencil and paper and tried to figure it out. But I figured, "with what everyone else is telling me, I could have done 20 percent better.”
fact @26428..26605 [cuts-against] | Plaintiffs expectation is rooted in an assumption that his application would be accepted, and that he would serve on an equal footing with all other doctors on the closed panel.
held @26772..26847 | He hopes to benefit from the Defendant’s allegedly anticompetitive conduct.
held @31032..31111 | He merely hopes to profit from the allegedly anticompetitive conduct of others.
gloss Court assumes the closed panel is an illegal restriction; a rival who wants in on the restricted arrangement is injured by being denied its fruits, not by reduced competition (Todorov).
element standing : not-satisfied [no-evidence]
count Count I (exclusion from closed-panel PPO)
party CFMA, Healthchoice
theory plaintiff wants the panel opened to all physicians (affidavit version)
variant efficient-enforcer/speculative-damages-from-hypothetical-open-market
fact @29137..29309 [cuts-against] | There are currently 2,200 licensed physicians in the Orlando area. Healthchoice presently has 863 physicians on its provider panel in Orange, Seminole and Osceola Counties.
fact @29310..29433 [cuts-against] | It is impossible to predict how many of the doctors not currently on the panel would choose to participate in Healthchoice.
fact @30172..30302 [cuts-against] | There is no way to know how many patients would choose Plaintiff as their internist or what services those patients would require.
rule @23502..23645 | A second factor is the nature of the plaintiffs damages claims. Id. If the claims are highly speculative,' the plaintiff may not have standing.
held @30615..30784 | It appears that any damages Plaintiff may be able to claim are highly speculative. Therefore, Plaintiff is not an efficient enforcer of this alleged antitrust violation.
element restraint.per-se : not-reached
role rule-announced
scope alternative
count Count I
variant per-se-rejected/closed-panel-ppo-effect-not-obvious
fact @2037..2201 [supports] | Some PPOs, including Healthc/ioice, use a limited or closed panel of providers. Healthc/mice determines the size of its provider panel under a need analysis system.
fact @34166..34241 [cuts-against] | Instead, statistics indicate purchasers are buying more managed care plans.
rule @34369..34441 | Plaintiff must, therefore, define the market and establish market power.
held @34242..34368 | Since the competitive effect is not immediately obvious, the Court would be unwilling to apply a per se approach in this case.
gloss Dictum (the court: "these observations are not essential to disposition"): the court says it would be unwilling to apply a per se approach and that the plaintiff would therefore have to define the market and prove market power. It decides only the would-be mode of analysis, not whether the closed panel is unreasonable. `scope alternative` is the nearest v1 scope for dictum.
element restraint.market-power : not-reached
scope alternative
count Count I
fact @34782..34859 [cuts-against] | He has limited the product market to a service rendered solely by Defendants.
gloss Court criticises a single-brand market (services to members of defendant's own PPO) as circular but expressly does not rest on it. The test sentence ("Plaintiff must, therefore, define the market and establish market power") is filed as the rule line of the restraint.per-se Count I block.
element agreement : not-reached
count Count I
element commerce : not-reached
misfit Alternative factual versions from the SAME plaintiff on the same count produce different failing elements: Count I fails on `injury` if he wants in (deposition) and on `standing` if he wants the panel opened (affidavit). `theory` now carries each version, but the court never chooses between them, and nothing says the two blocks are disjunctive (exactly one applies) rather than cumulative.
misfit Basis: these are summary-judgment rulings recorded as [no-evidence] per the v1 table, but the Count I injury ruling is closer to a legal characterisation of the plaintiff's own undisputed testimony (a rival who wants into the restricted arrangement suffers no antitrust injury) than to a failure of proof; [no-evidence] vs [law] is a judgement call the single basis slot hides.
misfit The court itself treats injury (standing) and restraint (anticompetitive effect on the merits) as nearly the same inquiry ("similar to requiring a plaintiff to show an antitrust injury"); the notation forces them into two independent element blocks with duplicated facts.
misfit `scope alternative` now marks the "even if standing" rulings on Count III, but v1 has no scope for DICTUM: the Count I per se / market-definition remarks ("not essential to disposition") are also filed as scope alternative, which overstates them (an alternative ground is a holding; dictum is not).
misfit Count II is a Sherman Act section 2 claim decided on the same standing reasoning; out of scope for this law directory but disposed of by the same held lines.
misfit The opinion's OCR renders the defendant's name inconsistently (Healthcfeoice, Healthc/mice, HealthcAoice); verbatim quotes preserve this, which will defeat any entity matching across fact lines.